Posted on: April 20, 2026
Does it excite you to provide medical and scientific leadership for innovative Inflammation & Rare Disease programs, and do you have experience leading teams across early clinical, late-stage development and lifecycle activities? If this sounds like you, and you are ready to take on a broad area of responsibilities, then you could be our new colleague.
Your new position
As Senior Director, Head of Inflammation & Rare Disease in Medical & Science, the role provides day-to-day medical and scientific leadership for Zealand Pharma’s Inflammation & Rare Disease projects across early clinical, late-stage development, and lifecycle. Reporting to the SVP, Head of Medical & Science, the position sets direction, ensures scientific rigor, and drives execution through strong cross-functional collaboration. This is a people leadership role with accountability for leading and developing a team of Medical Specialists supporting key portfolio priorities.
We offer exciting responsibilities:
Your profile
The ideal candidate is a collaborative and inclusive strong people leader with excellent medical judgment and a pragmatic, delivery-focused mindset. The role requires comfort operating in a complex, cross-functional environment and the ability to translate medical and scientific insight into clear direction for teams and projects. Communication is structured and effective across both scientific and non-scientific stakeholders.
Your new team
You will head the Inflammation & Rare Disease department within Medical & Science, leading a team of highly skilled and dedicated medical specialists. The department works closely with cross-functional project teams to provide medical and scientific input that strengthens development strategy and execution from early clinical through late-stage and lifecycle activities. The team partners broadly across the organization and with external experts to support high-quality decision-making and impactful outcomes.
Let's bond and be bold
We have a unique culture, characterized by excellent teamwork and strong engagement across the organization. And we want you to help us strengthen this culture.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other. We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Join us and let's bond and be bold.
Interested in bonding with us? Then please apply no later than April 30, 2026, or as soon as possible. The applications will be reviewed as they come in. While a cover letter is not required, please include a few sentences in your CV explaining your motivation for applying.
For further information, please contact SVP, Head of Medical & Science, Simon Skibsted: SSkibsted@zealandpharma.com.
We are committed to an inclusive recruitment process and welcome applications from all job applicants.
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary data platform that leverages advanced data-driven and AI/ML approaches, Zealand Pharma aims to lead a new era in obesity and metabolic health. To date, more than ten Zealand Pharma-invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization. Founded in 1998, Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts. Learn more at www.zealandpharma.com.
#LI-Onsite